Adolescent Type 1 Diabetes Treatment With SGLT2i for hyperglycEMia & hyPerfilTration Trial
Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
The ATTEMPT (Adolescent Type 1 diabetes Treatment with SGLT2i for hyperglycEMia &
hyPerfilTration Trial) is a multi-center, double-blinded, randomized, placebo-controlled
trial to evaluate the effect of treatment with Dapagliflozin when compared to placebo, in
combination with adjustable insulin, on measured GFR in adolescents with T1D 12 to <19 years
of age over a 16-week treatment period.
Phase:
Phase 3
Details
Lead Sponsor:
The Hospital for Sick Children
Collaborators:
Canadian Institutes of Health Research (CIHR) Juvenile Diabetes Research Foundation